espac-5f: four arm, prospective, multicentre, international randomised phase ii trial of
Published 3 years ago • 219 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
1:41
analyzing the espac-5f trial in borderline resectable pancreatic cancer
-
4:22
pancreatic cancer-associated diabetes improves following neoadjuvant therapy
-
3:07
the american pancreas association (apa)
-
3:47
neoadjuvant chemoradiotherapy beneficial for resectable pancreatic cancer | geertjan van tienhoven
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
1:26:53
updates on active pancreatic clinical trials
-
3:47
locally advanced pancreatic cancer: considering resection
-
50:26
neoadjuvant therapy for pancreatic cancer
-
1:56
algorithm for the diagnosis, staging, and treatment of pancreas masses (pancreatic adenocarcinoma)
-
19:50
88 strategy of conversion surgery for unresectable pancreatic cancer copy
-
10:56
debate: optimal adjuvant chemotherapy for resected pancreatic cancer - gemcitabine/capecitabine
-
18:09
92 surgical outcomes after pancreatic resection
-
4:04
pancreatic stellate nadph oxidase 1 facilitates the invasion of pancreatic cancer cells through the
-
20:05
89 shifting paradigms for the treatment of localized non metastatic pancreatic cancer
-
2:50
active targeting facilitates pancreatic cancer specific uptake of nanocontrast agents
-
8:36
extra-pancreatic ipmn
-
2:13
advances in the management of pancreatic cancer - line 4 stop 7 advanced pdac mutational load
-
0:48
localized pancreatic cancer